Phase II trial of pegylated liposomal doxorubicin as consolidation chemotherapy in patients with stage III or IV ovarian or primary peritoneil carcinoma.

被引：0
|
作者：
Disilvestro, PA
Fisher, M
Pearl, M
Valea, F
Buhl, A
Chalas, E
机构：
[1] Women & Infants Hosp Rhode Isl, Providence, RI USA
[2] SUNY Stony Brook, Stony Brook, NY 11794 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5112
引用
收藏
页码：477S / 477S
页数：1
相关论文
共 50 条
  • [31] A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancer
    Nakanishi, Toru
    Aoki, Daisuke
    Watanabe, Yoh
    Ando, Yuichi
    Tomotsugu, Naoki
    Sato, Yuji
    Saito, Toshiaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (05) : 422 - 426
  • [32] A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Keun Seok Lee
    Jungsil Ro
    Byung-Ho Nam
    Eun Sook Lee
    Youngmee Kwon
    Hye Soo Kwon
    Ki Wook Chung
    Han Sung Kang
    Eun A Kim
    Seok Won Kim
    Kyung Hwan Shin
    Seok-Ki Kim
    Breast Cancer Research and Treatment, 2008, 109 : 481 - 489
  • [33] Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer:: final results of a phase II trial
    Schmid, P
    Krocker, J
    Jehn, C
    Michniewicz, K
    Lehenbauer-Dehm, S
    Eggemann, H
    Heilmann, V
    Kümmel, S
    Schulz, CO
    Dieing, A
    Wischnewsky, MB
    Hauptmann, S
    Elling, D
    Possinger, K
    Flath, B
    ANNALS OF ONCOLOGY, 2005, 16 (10) : 1624 - 1631
  • [34] Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients
    Rocconi, Rodney P.
    Straughn, J. Michael, Jr.
    Leath, Charles A., III
    Kilgore, Larry C.
    Huh, Warner K.
    Barnes, Mack N., III
    Partridge, Edward E.
    Alvarez, Ronald D.
    ONCOLOGIST, 2006, 11 (04): : 336 - 341
  • [35] A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer
    Recchia, Francesco
    Saggio, Gaetano
    Amiconi, Giovanna
    Di Blasio, Anna
    Cesta, Alisia
    Candeloro, Giampiero
    Carta, Gaspare
    Necozione, Stefano
    Mantovani, Giovanni
    Rea, Silvio
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 164 - 169
  • [36] A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin
    Mirza, Mansoor Raza
    Lund, Bente
    Lindegaard, Jacob Christian
    Keldsen, Nina
    Mellemgaard, Anders
    Christensen, Rene dePont
    Bertelsen, Kamma
    GYNECOLOGIC ONCOLOGY, 2010, 119 (01) : 26 - 31
  • [37] Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer
    Nicoletto, MO
    Falci, C
    Pianalto, D
    Artioli, G
    Azzoni, P
    De Masi, G
    Ferrazzi, E
    Perin, A
    Donach, M
    Zoli, W
    GYNECOLOGIC ONCOLOGY, 2006, 100 (02) : 318 - 323
  • [38] Chemotherapy-induced dyspareunia: a case study of vaginal mucositis and pegylated liposomal doxorubicin injection in advanced stage ovarian carcinoma
    Krychman, ML
    Carter, J
    Aghajanian, CA
    Dizon, DS
    Castiel, M
    GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 561 - 563
  • [39] Association of pegylated liposomal doxorubicin (PLD) and ifosfamide (IFO) in early recurrent ovarian cancer patients: A multicenter phase II trial.
    Chinet-Charrot, P
    Joly, F
    Bourgeois, H
    Lortholary, A
    Leduc, B
    Priou, F
    Cumin, I
    Sevin, E
    Hamond, K
    Henry-Amar, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 465S - 465S
  • [40] Adjuvant chemotherapy with temozolomide and pegylated liposomal doxorubicin in the first-line therapy of patients with glioblastoma - A phase-II trial.
    Hau, P
    Jauch, T
    Hirschmann, B
    Drechsel, E
    Grauer, O
    Koch, H
    Wismeth, C
    Steinbrecher, A
    Bogdahn, U
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 118S - 118S
12345